Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Lauffer

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2026
The role of inflammatory cell death in type 1 dominant inflammatory skin diseasesFelix Lauffer
Dermatologie (Heidelberg, Germany)|May 24, 2022
[Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience]Felix Lauffer, Tilo Biedermann
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2023
Ekzematisierte Psoriasis - eine häufige, aber oft vernachlässigte Variante der Plaque-PsoriasisFelix Lauffer, Kilian Eyerich
Allergy|May 19, 2026
From Sprinters to Marathoners: Rethinking Therapeutic Speed and Disease Modification in Atopic DermatitisThomas Bieber, Felix Lauffer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2023
Eczematized psoriasis - a frequent but often neglected variant of plaque psoriasisFelix Lauffer, Kilian Eyerich
Expert Opinion on Emerging Drugs|January 26, 2016
Target-oriented therapy: Emerging drugs for atopic dermatitisFelix Lauffer, Johannes Ring
Experimental Dermatology|October 8, 2016
Molecular diagnostics of inflammatory disease: New tools and perspectivesNatalie Garzorz-Stark, Felix Lauffer
Acta Dermato-Venereologica|January 27, 2022
Treatment of Atopic Dermatitis with Baricitinib: First Real-life ExperienceDanielle Rogner, Tilo Biedermann, Felix Lauffer
Dermatologie (Heidelberg, Germany)|September 21, 2022
[Papules, plaques and pruritus]Christina Schmitt, Felix Lauffer, Tilo Biedermann, et al.
Biomedicines|November 27, 2021
Bisphosphonates for the Treatment of Calcinosis Cutis-A Retrospective Single-Center StudyLilian Rauch, Rüdiger Hein, Tilo Biedermann, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2026
The role of inflammatory cell death in type 1 dominant inflammatory skin diseasesFelix Lauffer
Dermatologie (Heidelberg, Germany)|May 24, 2022
[Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience]Felix Lauffer, Tilo Biedermann
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2023
Ekzematisierte Psoriasis - eine häufige, aber oft vernachlässigte Variante der Plaque-PsoriasisFelix Lauffer, Kilian Eyerich
Allergy|May 19, 2026
From Sprinters to Marathoners: Rethinking Therapeutic Speed and Disease Modification in Atopic DermatitisThomas Bieber, Felix Lauffer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2023
Eczematized psoriasis - a frequent but often neglected variant of plaque psoriasisFelix Lauffer, Kilian Eyerich
Expert Opinion on Emerging Drugs|January 26, 2016
Target-oriented therapy: Emerging drugs for atopic dermatitisFelix Lauffer, Johannes Ring
Experimental Dermatology|October 8, 2016
Molecular diagnostics of inflammatory disease: New tools and perspectivesNatalie Garzorz-Stark, Felix Lauffer
Acta Dermato-Venereologica|January 27, 2022
Treatment of Atopic Dermatitis with Baricitinib: First Real-life ExperienceDanielle Rogner, Tilo Biedermann, Felix Lauffer
Dermatologie (Heidelberg, Germany)|September 21, 2022
[Papules, plaques and pruritus]Christina Schmitt, Felix Lauffer, Tilo Biedermann, et al.
Biomedicines|November 27, 2021
Bisphosphonates for the Treatment of Calcinosis Cutis-A Retrospective Single-Center StudyLilian Rauch, Rüdiger Hein, Tilo Biedermann, et al.
Pageof 4